These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 6936974)

  • 1. [Control of leukaemic and normal myeloid haemopoietic cells (author's transl)].
    Hinterberger W; Paukovits W
    Wien Klin Wochenschr; 1980 Sep; 92(18):650-4. PubMed ID: 6936974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The colony-stimulating factors and myeloid leukaemia.
    Nicola NA; Metcalf D
    Cancer Surv; 1985; 4(4):789-815. PubMed ID: 3916644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the presence in sera from chronic myelogenous leukemia patients of an activity that enhances the number of normal bone marrow-derived granulocyte/monocyte committed stem cell colonies.
    Rao SG; Kothari V; Nadkarni K; Ahuja H; Advani S
    Nouv Rev Fr Hematol (1978); 1987; 29(4):231-6. PubMed ID: 3501108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The determination of myeloid-committed stem cells in systemic disorders of myelopoiesis: implications for physiopathology, diagnosis and prognosis].
    Hinterberger W
    Acta Med Austriaca Suppl; 1981; 21():1-20. PubMed ID: 6949436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of human myeloid leukemia cells to various sources of colony-stimulating activity and phytohemagglutinin-conditioned medium.
    Taetle R; Caviles A; Koziol J
    Cancer Res; 1983 May; 43(5):2350-7. PubMed ID: 6600965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulation of growth and development of normal and leukaemic cells.
    Dexter TM; Allen TD
    J Pathol; 1983 Nov; 141(3):415-33. PubMed ID: 6363652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clone size potential and sensitivity to colony-stimulating activity: differentiation-linked properties of granulocyte-macrophage progenitor cells.
    Francis GE; Berney JJ; Bodger MP; Bol SJ; Wing MA; Hoffbrand AV
    Stem Cells (1981); 1981; 1(2):124-39. PubMed ID: 6983149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of granulocyte and monocyte-macrophage proliferation by colony stimulating factor (CSF): a review.
    Metcalf D
    Exp Hematol; 1973; 1(4):185-201. PubMed ID: 4608467
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
    Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
    Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures.
    Güenechea G; Bueren JA; Maganto G; Tuduri P; Guerrero A; Pivel JP; Real A
    Stem Cells; 1995 Mar; 13(2):175-85. PubMed ID: 7540471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term culture of autologous transplanted bone marrow for acute myeloid leukaemia: evidence for an in vitro haemopoietic defect and lack of correlation with the speed of engraftment.
    Straetmans N; Ma DD; Herman P; Zenebergh A; Chang A; Deneys V; De Bruyère M; Ferrant A
    Bone Marrow Transplant; 1995 Mar; 15(3):421-8. PubMed ID: 7599567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E1.
    Pelus LM; Broxmeyer HE; Clarkson BD; Moore MA
    Cancer Res; 1980 Jul; 40(7):2512-5. PubMed ID: 6930324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro differentiation of murine Sca-1+Lin- cells into myeloid, B cell and T cell lineages.
    Ito M; Anan K; Misawa M; Kai S; Hara H
    Stem Cells; 1996 Jul; 14(4):412-8. PubMed ID: 8843542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N; Chertkov J; Samoilina N; Zander A
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct actions of Flt3 ligand and stem cell factor on myeloid lineage selection and maturation of granulocytes versus macrophages.
    Dannaeus K; Nilsson K; Jönsson JI
    Exp Hematol; 1998 Apr; 26(4):345-52. PubMed ID: 9546318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral regulation of granulopoiesis.
    Moore MA
    Clin Haematol; 1979 Jun; 8(2):287-309. PubMed ID: 158453
    [No Abstract]   [Full Text] [Related]  

  • 18. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting the growth and differentiation of haemopoietic cells in culture.
    Stanley ER; Jubinsky PT
    Clin Haematol; 1984 Jun; 13(2):329-48. PubMed ID: 6088143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel anti-inflammatory function of human galectin-1: inhibition of hematopoietic progenitor cell mobilization.
    Kiss J; Kunstár A; Fajka-Boja R; Dudics V; Tóvári J; Légrádi A; Monostori E; Uher F
    Exp Hematol; 2007 Feb; 35(2):305-13. PubMed ID: 17258079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.